サマリー

自動車用サラウンドビューシステムの世界市場 2022-2026 年
Technavioは自動車用サラウンドビューシステム市場を監視しており、2022-2026年の間に96億ドルの成長が見込まれ、予測期間中にCAGR 15.74%で加速しています。当レポートでは、自動車用サラウンドビューシステム市場の全体分析、市場規模・予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境など、最新の分析を提供しています。市場を牽引するのは、手頃な価格のカメラアシスト安全技術につながる技術の進歩、商用車におけるADASおよび先進安全システムの普及率の上昇、自動車の後退中の歩行者死亡数の増加などがADASの需要を後押ししています。
自動車用サラウンドビューシステム市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioの自動車用サラウンドビューシステム市場は、以下のようにセグメント化されています。
タイプ別
- 乗用車
- 商用車
地域別
- 欧州
- 北アメリカ
- アジア太平洋地域
- 中近東・アフリカ
- 南米
本調査では、高解像度カメラの開発が、今後数年間の自動車用サラウンドビューシステム市場の成長を牽引する主要な要因の1つであると特定しています。また、サラウンドビューシステム用のカメラクリーニングシステムや、ドライバーレスカー用のカメラベースの安全技術の開発は、市場の大きな需要につながるでしょう。
Technavioは、主要パラメータの分析により、複数のソースからのデータを調査、合成、総括することで、市場の詳細な姿を提示します。自動車用サラウンドビューシステム市場に関する当レポートでは、以下の分野をカバーしています。
- 車載用サラウンドビューシステム市場のサイジング
- 車載用サラウンドビューシステム市場予測
- 車載用サラウンドビューシステム市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Advanced Micro Devices Inc.、Ambarella Inc,BorgWarner Inc.、Continental AG、FURUKAWA Co. Ltd、Gazer Ltd、Intel Corp.、Kocchi Technology Hong Kong Ltd、Magna International Inc.、NXP Semiconductors NV、OMNIVISION Technologies Inc、Olaco Products BV、Renesas Electronics Corp.、Robert Bosch GmbH、Samsung Electronics Co.Ltd.、Spillard Safety Systems Ltd.、Stellantis NV、Texas Instruments Inc.、Valeo SAがあります。また、自動車用サラウンドビューシステム市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/automotive-surround-view-systems-market-industry-analysis をご覧ください。
Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメータを分析し、複数の情報源からのデータを調査、合成、総括することで、市場の詳細な姿を提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Therapy
o 5.1 Market segments
o Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
o 5.2 Comparison by Therapy
o Exhibit 26: Chart on Comparison by Therapy
o Exhibit 27: Data Table on Comparison by Therapy
o 5.3 First line treatment - Market size and forecast 2021-2026
o Exhibit 28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
o 5.4 Second line treatment - Market size and forecast 2021-2026
o Exhibit 32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Therapy
o Exhibit 36: Market opportunity by Therapy ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Amgen Inc.
o Exhibit 85: Amgen Inc. - Overview
o Exhibit 86: Amgen Inc. - Product / Service
o Exhibit 87: Amgen Inc. - Key offerings
o 10.4 AMYRA Biotech AG
o Exhibit 88: AMYRA Biotech AG - Overview
o Exhibit 89: AMYRA Biotech AG - Product / Service
o Exhibit 90: AMYRA Biotech AG - Key offerings
o 10.5 BioLineRx Ltd.
o Exhibit 91: BioLineRx Ltd. - Overview
o Exhibit 92: BioLineRx Ltd. - Product / Service
o Exhibit 93: BioLineRx Ltd. - Key offerings
o 10.6 Bristol Myers Squibb Co.
o Exhibit 94: Bristol Myers Squibb Co. - Overview
o Exhibit 95: Bristol Myers Squibb Co. - Product / Service
o Exhibit 96: Bristol Myers Squibb Co. - Key offerings
o 10.7 Calypso Biotech
o Exhibit 97: Calypso Biotech - Overview
o Exhibit 98: Calypso Biotech - Product / Service
o Exhibit 99: Calypso Biotech - Key offerings
o 10.8 GlaxoSmithKline Plc
o Exhibit 100: GlaxoSmithKline Plc - Overview
o Exhibit 101: GlaxoSmithKline Plc - Business segments
o Exhibit 102: GlaxoSmithKline Plc - Key news
o Exhibit 103: GlaxoSmithKline Plc - Key offerings
o Exhibit 104: GlaxoSmithKline Plc - Segment focus
o 10.9 Immunogenics LLC
o Exhibit 105: Immunogenics LLC - Overview
o Exhibit 106: Immunogenics LLC - Product / Service
o Exhibit 107: Immunogenics LLC - Key offerings
o 10.10 Johnson and Johnson
o Exhibit 108: Johnson and Johnson - Overview
o Exhibit 109: Johnson and Johnson - Business segments
o Exhibit 110: Johnson and Johnson - Key news
o Exhibit 111: Johnson and Johnson - Key offerings
o Exhibit 112: Johnson and Johnson - Segment focus
o 10.11 Sanofi
o Exhibit 113: Sanofi - Overview
o Exhibit 114: Sanofi - Business segments
o Exhibit 115: Sanofi - Key news
o Exhibit 116: Sanofi - Key offerings
o Exhibit 117: Sanofi - Segment focus
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 122: Inclusions checklist
o Exhibit 123: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 124: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 125: Research methodology
o Exhibit 126: Validation techniques employed for market sizing
o Exhibit 127: Information sources
o 11.5 List of abbreviations
o Exhibit 128: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy
Exhibits27: Data Table on Comparison by Therapy
Exhibits28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Therapy ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: AMYRA Biotech AG - Overview
Exhibits89: AMYRA Biotech AG - Product / Service
Exhibits90: AMYRA Biotech AG - Key offerings
Exhibits91: BioLineRx Ltd. - Overview
Exhibits92: BioLineRx Ltd. - Product / Service
Exhibits93: BioLineRx Ltd. - Key offerings
Exhibits94: Bristol Myers Squibb Co. - Overview
Exhibits95: Bristol Myers Squibb Co. - Product / Service
Exhibits96: Bristol Myers Squibb Co. - Key offerings
Exhibits97: Calypso Biotech - Overview
Exhibits98: Calypso Biotech - Product / Service
Exhibits99: Calypso Biotech - Key offerings
Exhibits100: GlaxoSmithKline Plc - Overview
Exhibits101: GlaxoSmithKline Plc - Business segments
Exhibits102: GlaxoSmithKline Plc - Key news
Exhibits103: GlaxoSmithKline Plc - Key offerings
Exhibits104: GlaxoSmithKline Plc - Segment focus
Exhibits105: Immunogenics LLC - Overview
Exhibits106: Immunogenics LLC - Product / Service
Exhibits107: Immunogenics LLC - Key offerings
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Sanofi - Overview
Exhibits114: Sanofi - Business segments
Exhibits115: Sanofi - Key news
Exhibits116: Sanofi - Key offerings
Exhibits117: Sanofi - Segment focus
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations